Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001584759-26-000012

Director sold 300 shares at $12.00 ($3,600)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Heyman Richard A. Director 2026-07-06 Sale 10b5-1 −300 $12.00 $3,600 212,772 I: show line 1 in the form
Open-market sales · 300 sh · avg $12.00 · $3,600
Loading xslF345X06/form4-07082026_080727.xml…